Form 4 for PRU Prudential Financial
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001127602-25-004438 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-12 | 2025-02-10 | PRU | Frias Yanela | EVP, CFO | M - OptEx | $0.00 | +3,292 | 17.4K | +23% | $0 |
| D | 2025-02-12 | 2025-02-10 | PRU | Frias Yanela | EVP, CFO | F - Tax | $112.09 | -1,238 | 16.1K | -7% | -$138.8K |
| DM | 2025-02-12 | 2025-02-10 | PRU | Frias Yanela | EVP, CFO | A - Grant | $0.00 | +28.6K | 7,138 | New | $0 |
| D | 2025-02-12 | 2025-02-10 | PRU | Frias Yanela | EVP, CFO | M - OptEx | $0.00 | -4,039 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-10 | M | A | 3,292 | $0.00 | 17,356 | D | — | — | (F1) The Compensation and Human Capital Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to the ROE performance of a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. |
| 2 | Common | Common Stock | 2025-02-10 | F | D | 1,238 | $112.09 | 16,118 | D | — | — | (F2) Represents shares withheld for the payment of taxes. |
| 3 | Derivative | 2025 Performance Shares | 2025-02-10 | A | A | 21,412 | $0.00 | 21,412 | D | $0.00 · — to — | 21,412 Common Stock | (F6) The performance shares convert to common stock on a 1 to 1 basis. (F7) Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation and Human Capital Committee in February 2028 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2025 through 2027 performance period. |
| 4 | Derivative | 2025 Restricted Stock Units | 2025-02-10 | A | A | 7,138 | $0.00 | 7,138 | D | $0.00 · — to — | 7,138 Common Stock | (F4) The Restricted Stock Units convert to common stock on a 1 to 1 basis. (F5) The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2026. |
| 5 | Derivative | 2022 Performance Shares | 2025-02-10 | M | D | 4,039 | $0.00 | 0 | D | — · — to — | 4,039 Common Stock | (F1) The Compensation and Human Capital Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to the ROE performance of a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. |